Your browser doesn't support javascript.
loading
Emergence of individual HIV-specific CD8 T cell responses during primary HIV-1 infection can determine long-term disease outcome.
Streeck, Hendrik; Lu, Richard; Beckwith, Noor; Milazzo, Mark; Liu, Michelle; Routy, Jean-Pierre; Little, Susan; Jessen, Heiko; Kelleher, Anthony D; Hecht, Frederick; Sekaly, Rafick-Pierre; Alter, Galit; Heckerman, David; Carrington, Mary; Rosenberg, Eric S; Altfeld, Marcus.
Afiliación
  • Streeck H; U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, USA Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, Maryland, USA Ragon Institute of MGH, MIT and Harvard, Cambridge, Massachusetts, USA hstreeck@hivresearch.org.
  • Lu R; U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, USA Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, Maryland, USA.
  • Beckwith N; Harvard School of Medicine, Boston, Massachusetts, USA.
  • Milazzo M; U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, USA Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, Maryland, USA.
  • Liu M; U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, USA Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, Maryland, USA.
  • Routy JP; McGill University, Division of Hematology and Immunodeficiency Service, Royal Victoria Hospital, Montreal, Quebec, Canada.
  • Little S; Department of Medicine, University of California, San Diego, San Diego, California, USA.
  • Jessen H; HIV Clinic Praxis Jessen, Berlin, Germany.
  • Kelleher AD; Kirby Institute, UNSW, Sydney, New South Wales, Australia.
  • Hecht F; Department of Medicine, San Francisco General Hospital, University of California, San Francisco, California, USA.
  • Sekaly RP; Division of Infectious Diseases, Vaccine and Gene Therapy Institute-Florida, Port Saint Lucie, Florida, USA.
  • Alter G; Ragon Institute of MGH, MIT and Harvard, Cambridge, Massachusetts, USA.
  • Heckerman D; eScience Group, Microsoft Research, Los Angeles, California, USA.
  • Carrington M; Ragon Institute of MGH, MIT and Harvard, Cambridge, Massachusetts, USA Cancer and Inflammation Program, Laboratory of Experimental Immunology, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA.
  • Rosenberg ES; Massachussetts General Hospital, Boston, Massachusetts, USA.
  • Altfeld M; Ragon Institute of MGH, MIT and Harvard, Cambridge, Massachusetts, USA Heinrich-Pette-Institute, Hamburg-Eppendorf, Germany.
J Virol ; 88(21): 12793-801, 2014 Nov.
Article en En | MEDLINE | ID: mdl-25165102
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Infecciones por VIH / VIH-1 / Linfocitos T CD8-positivos Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Female / Humans / Male Idioma: En Revista: J Virol Año: 2014 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Infecciones por VIH / VIH-1 / Linfocitos T CD8-positivos Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Female / Humans / Male Idioma: En Revista: J Virol Año: 2014 Tipo del documento: Article País de afiliación: Estados Unidos